It has been discovered that patients showing a strong response or complete response to nCRT have a significantly lower expression of FGFR4 in their tumor tissue, whereas patients with high FGFR4 expression correlated with poor radiosensitivity (p = 0.04) [40]. The gene discussed is FGFR4; the disease is neoplasm.